Financials

News Discussions Technicals Forecast Seasonals Options

ELVN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Enliven Therapeutics, Inc.

Total assets of ELVN for Q1 25 is 302.57 M USD, 7.12% less than the previous Q4 24. And total liabilities decreased by 10.31% in Q1 25 to 14.27 M USD.

Q3 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD